Woven Science’s El Puente foundation is pleased to release for public comment its policy paper and corporate social responsibility initiative for psychedelic pharmaceutical companies to engage with indigenous peoples using psychedelic botanicals in traditional practice. This paper explores how public policymakers in collaboration with companies can offer indigenous communities influence over product development, consumer preferences, […]
Read MoreDay: October 19, 2021
The Foundation for Dermatology Education to Host the 3rd Annual Live Revolutionizing Atopic Dermatitis (RAD) Conference – Saturday, December 11 – Monday, December 13, 2021
Registration now open to the only global multidisciplinary conference featuring world-class speakers, cutting-edge research presentations, case study reviews and more specifically in the field of Atopic Dermatitis CHICAGO, Oct. 19, 2021 (GLOBE NEWSWIRE) — The 3rd Annual Live Revolutionizing Atopic Dermatitis (RAD) Conference will be held virtually this year from Saturday, December 11 – Monday, December 13 and will […]
Read MoreWebtel.mobi Describes the Extremely Wide Range of Capacities and Responsibilities for Digital Currency and CBDC Development
As WM has already developed and tested its functioning Global, Digital and multicurrency Digital currency for nearly a decade, it is aware of all the capacities of such instruments, and the responsibilities that go hand-in-hand with its creation and usage WM’s TUVs NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) — At this time, multiple entities […]
Read MoreAmbulero’s Gene Therapy Candidate AMB-301 Granted US Orphan Drug Designation For Treatment of Severe Vascular Disease
Ambulero Inc Receives Key FDA Recognition For Novel Gene Therapy To Treat Buerger’s Disease (Thromboangiitis Obliterans) MIAMI, Oct. 19, 2021 (GLOBE NEWSWIRE) — Ambulero Inc., a biotechnology company (“Ambulero” or the “Company”) developing new cell and gene therapy treatments for patients suffering from severe vascular disease, today announced that the U.S. FDA’s Office For Orphan […]
Read MoreHqO Acquires Leading European Tenant Experience Platform Office App
Unified Top Companies Bring Unmatched Global Capabilities for Workplace Experience BOSTON, Oct. 19, 2021 (GLOBE NEWSWIRE) — HqO, the end-to-end tenant experience platform for commercial real estate properties, today announces that it has acquired Office App, a leading European tenant and employee engagement platform. The new combined entity is valued at over half a billion dollars, making […]
Read MoreThe Art of Science: Olympus Launches Third Global Image of the Year Contest
The annual awards celebrate the beauty of the microscopic world through imaging Olympus Image of the Year Award 2021 WALTHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — Olympus’ third annual Global Image of the Year Life Science Light Microscopy Award is now open for entries through Jan. 31, 2022. Each year, the competition recognizes the […]
Read MoreNew Research Uncovers Necessary Skills for Businesses to Drive Systemic Progress for Diversity, Equity, Inclusion and Belonging (DEIB)
New report from RedThread Research and Degreed uncovers the actionable skills that build more diverse organizations, including assertiveness, grit, authenticity, and curiosity PLEASANTON, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — A new report, Creating a DEIB Culture: The Skills Every Employee Needs, by RedThread Research and sponsored by Degreed, has uncovered the actionable skills that build […]
Read MoreAdagio Therapeutics Announces New In Vitro Data Highlighting Broad and Potent Neutralization of ADG20 Against All Known SARS-CoV-2 Variants
Data to be presented at the 2021 ISIRV-WHO Virtual Conference WALTHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced new in vitro data demonstrating retained neutralizing activity of its monoclonal antibody […]
Read More